Literature DB >> 10331302

[Dexamethasone-induced apoptosis in peripheral T lymphocytes from patients with asthma].

K Oneda1.   

Abstract

The corticosteroid is effective for treating allergic inflammation. However, the mechanisms of the effectiveness are still unclarified. In this study, we examined whether dexamethasone, one of corticosteroids, can induce apoptosis in peripheral T cells from patients with asthma. Dexamethasone induced significantly greater apoptosis in T cells from patients with asthma than from normal subjects at 10(-4) M and 10(-5) M (p < 0.05). Apoptosis was assessed by flow cytometry, DNA fragmentation. By examining the function of T cell subsets, the augmentation of apoptosis was ascribed to CD4+HLADR+CD25+subsets. Elimination of HLADR+CD25+subsets from T cells caused a great reduction in IL-5 production and proliferation to mite on Day 3, suggesting that the subset might be primed by mite allergen. Dexamethasone may reduce allergen specific T cells through apoptosis, which is one of the mechanisms of effectiveness of dexamethasone in asthmatics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331302

Source DB:  PubMed          Journal:  Arerugi        ISSN: 0021-4884


  3 in total

1.  Pharmacokinetic/pharmacodynamic modeling of total lymphocytes and selected subtypes after oral budesonide.

Authors:  Jeffrey G Stark; Sybille Werner; Susanne Homrighausen; Yufei Tang; Michael Krieg; Hartmut Derendorf; Helmut Moellmann; Guenther Hochhaus
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-04-22       Impact factor: 2.745

2.  Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats.

Authors:  Zhenling Yao; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

3.  Multiple in vitro and in vivo regulatory effects of budesonide in CD4+ T lymphocyte subpopulations of allergic asthmatics.

Authors:  Elisabetta Pace; Caterina Di Sano; Stefania La Grutta; Maria Ferraro; Giuseppe Albeggiani; Giuseppe Liotta; Serena Di Vincenzo; Carina Gabriela Uasuf; Jean Bousquet; Mark Gjomarkaj
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.